Kronheim S, Berelowitz M, Pimstone B L
Diabetes. 1978 May;27(5):523-9. doi: 10.2337/diab.27.5.523.
We describe the characterization of somatostatin-like immunoreactivity (SRIF-LI) found by radioimmunoassay (RIA) to be present in normal human serum. Degradation by serum of 125I-Tyr1 SRIF in the assay, as assessed by chromatoelectrophoresis and immunoprecipitation, was overcome by using EDTA in the assay buffer and Trasylol in the blood samples. Serum samples thus obtained from 48 normal subjects revealed a bimodal distribution of SRIF-LI; 92 per cent (group 1) had a mean level of 0.274 +/- 0.009 ng. per milliliter. What was measured in these sera showed identity to synthetic SRIF on serial dilutions, Sephadex G-25 chromatography, and thin-layer chromatography, and it was shown to be immunoreactive by an antibody-Sepharose affinity system. Higher levels (1.0 +/- 0.041 ng. per milliliter) were found in 8 per cent of the sera; 50 per cent of this material behaved identically as serum SRIF-LI from group 1. The remainder proved to be heterogeneous, consisting of two peaks of large molecular weight, both of which shared immunologic identity with synthetic SRIF as shown by binding to the antibody-Sepharose affinity system. Their further nature is unknown.
我们描述了通过放射免疫测定法(RIA)发现的正常人类血清中存在的生长抑素样免疫反应性(SRIF-LI)的特征。通过色谱电泳和免疫沉淀评估,在测定中血清对125I-Tyr1 SRIF的降解可通过在测定缓冲液中使用乙二胺四乙酸(EDTA)和在血样中使用抑肽酶来克服。从48名正常受试者获得的血清样本显示SRIF-LI呈双峰分布;92%(第1组)的平均水平为每毫升0.274±0.009纳克。在这些血清中检测到的物质在系列稀释、葡聚糖凝胶G-25色谱和薄层色谱上与合成SRIF相同,并且通过抗体-琼脂糖亲和系统显示具有免疫反应性。8%的血清中发现了更高的水平(每毫升1.0±0.041纳克);该物质的50%与第1组血清SRIF-LI的行为相同。其余部分被证明是异质的,由两个大分子质量峰组成,通过与抗体-琼脂糖亲和系统结合表明,这两个峰均与合成SRIF具有免疫同一性。它们的进一步性质尚不清楚。